Peptas Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-07-2024
- Paid Up Capital ₹ 0.10 M
as on 30-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 135.75%
(FY 2023)
- Profit 90.26%
(FY 2023)
- Ebitda 77.91%
(FY 2023)
- Net Worth 191.77%
(FY 2023)
- Total Assets 32.76%
(FY 2023)
About Peptas Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raghavi Karumuri and Sivaji Maganti serve as directors at the Company.
- CIN/LLPIN
U24290TG2018PTC125141
- Company No.
125141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Peptas Pharma Private Limited offer?
Peptas Pharma Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Medicinal Roots.
Who are the key members and board of directors at Peptas Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghavi Karumuri  | Director | 15-Jun-2018 | Current |
| Sivaji Maganti | Director | 15-Jun-2018 | Current |
Financial Performance of Peptas Pharma.
Peptas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 135.75% increase. The company also saw a substantial improvement in profitability, with a 90.26% increase in profit. The company's net worth Soared by an impressive increase of 191.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Peptas Pharma?
In 2023, Peptas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Peptas Pharma?
Unlock and access historical data on people associated with Peptas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peptas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peptas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
